Catheter-related bloodstream infections (CRBSIs) are complications associated with the use of central venous catheters, generally involving a catheter hub or insertion site infection that leads to bacteremia. Central venous catheters are medical devices commonly used to deliver nutrition, fluids, blood products, antibiotics or chemotherapy to patients. However, prolonged use of central venous catheters poses a risk of catheter colonization and subsequent infection. Catheters are made of various materials like silicone, polyurethane and polymers coated with antimicrobial agents. The need for long term venous access in healthcare settings has contributed significantly to the rise of CRBSIs.
The Global Catheter Related Blood Stream Infection Market is estimated to be valued at US$ 1875.01 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in The Catheter Related Blood Stream Infection Market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co., Ltd, Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd., Matrica S.p.A., Nantong Hengxing Electronic Materials Co., Ltd., Nantong Jinghua Pharmaceutical Co., Ltd., Wufeng Chicheng Biotech Co., Ltd., and Xi'an Sonwu Biotech Co., Ltd. BASF SE and Croda International plc are among the leading players owing to their diverse product portfolios and global presence.
The growing incidence of healthcare-associated infections, increasing cancer cases and rising geriatric population are primary factors driving the demand for central venous catheters. This has significantly contributed to the risk of CRBSIs. According to CDC, over 250,000 CRBSIs occur annually in the US, resulting in extensive healthcare costs and increased length of hospital stays.
The market is witnessing increased focus on expanding globally with focus on emerging Asian markets. Key players are investing in product innovation, new coating technologies and partnerships to strengthen their distribution networks across Asia Pacific, Middle East, Latin America and Africa. This is expected to boost the adoption of prevention and treatment solutions for CRBSIs.
Market drivers
The key driver for the Catheter related blood stream infection market is the increasing prevalence of healthcare-associated infections. As per WHO, over 1.4 million patients suffer from healthcare associated infections annually across Europe alone. Prolonged hospitalization increases the vulnerability of patients to nosocomial pathogens. Moreover, extensive use of invasive medical devices like urinary catheters and central lines has contributed to the risk of catheter related pathogens entering the bloodstream. This has greatly influenced the demand for improved infection control and prevention in healthcare settings.
The geopolitical situation is impacting the growth of the Catheter Related Blood Stream Infection market in multiple ways. With ongoing conflicts and tensions between certain countries, international travel and trade has become more difficult. This poses challenges for medical device companies that rely on global supply chains and market access. Restrictions on the flow of goods and materials across borders can disrupt production timelines and affect the availability of critical supplies. It also limits the ability of companies to reach new international customers. Going forward, market players will need to diversify their supply networks and manufacturing footprints across different geographies to mitigate political risks. They should also look at expanding digitally to open up new sales channels that do not depend on physical trade routes. Developing strong local partnerships in strategically important regions can help gain insights into emerging policy changes and maintain business continuity even during times of adversity. At the same time, greater domestic spending on healthcare in the wake of security threats bodes well for medical technologies that enhance infection control and patient safety.
The United States currently accounts for the largest share of the global Catheter Related Blood Stream Infection market in terms of value. This is attributed to factors such as the country's advanced healthcare system, high medical spending and presence of leading market participants. However, the Asia Pacific region is poised to witness the fastest growth over the forecast period. This is mainly owing to rising penetration of CRBSI diagnostic procedures supported by growing healthcare investments, increasing incidence of hospital acquired infections and expanding medical tourism in the region's emerging economies such as China and India. Countries in Southeast Asia, the Middle East and Latin America also present lucrative business opportunities for Catheter Related Blood Stream Infection market players given their thriving medical devices industry and large patient pools.
The Asia Pacific region holds significant growth potential for the Catheter Related Blood Stream Infection market. Rising healthcare access and expanding medical insurance coverage in Asia Pacific countries are enabling more patients to undertake critical procedures that utilize vascular catheters. According to medical experts, the risk of catheter associated infections is also progressively increasing in this region’s hospitals and clinics due to overstretched medical staff and infrastructure. In order to address this issue, governments have stepped up efforts to establish antimicrobial stewardship and infection control programs. Also, growing awareness about hygiene maintenance is propelling the demand for preventive technologies. These favorable macro trends are attracting global medical device innovators to tap into the opportunities offered by the Asia Pacific Catheter Related Blood Stream Infection landscape.
Get more insights on Catheter-Related Bloodstream Infections Market
Check below trending Global Sustainable Fashion Market
